In contrast, the supplementation of eugenol to DENA/AAF-administered rats lowered the increased levels of MCP-1, reflecting the anticancer and anti-inflammatory efficacy of eugenol against lung cancer and further revealing that eugenol may be crucial for reducing lung inflammation and preventing lung cancer. The gene discussed is CCL2; the disease is lung carcinoma.